These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
386 related items for PubMed ID: 16697503
1. Maternal intranasal immunization with outer membrane protein P6 maintains specific antibody level of derived offspring. Yamauchi K, Hotomi M, Billal DS, Suzumoto M, Yamanaka N. Vaccine; 2006 Jun 19; 24(25):5294-9. PubMed ID: 16697503 [Abstract] [Full Text] [Related]
3. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide. Noda K, Kodama S, Umemoto S, Nomi N, Hirano T, Suzuki M. Microbiol Immunol; 2011 Aug 19; 55(8):574-81. PubMed ID: 21605159 [Abstract] [Full Text] [Related]
4. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx. Abe N, Kodama S, Hirano T, Eto M, Suzuki M. Laryngoscope; 2006 Mar 19; 116(3):407-12. PubMed ID: 16540899 [Abstract] [Full Text] [Related]
5. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529. Mason KW, Zhu D, Scheuer CA, McMichael JC, Zlotnick GW, Green BA. Vaccine; 2004 Sep 03; 22(25-26):3449-56. PubMed ID: 15308371 [Abstract] [Full Text] [Related]
10. Intranasal vaccination with recombinant P6 protein and adamantylamide dipeptide as mucosal adjuvant confers efficient protection against otitis media and lung infection by nontypeable Haemophilus influenzae. Bertot GM, Becker PD, Guzmán CA, Grinstein S. J Infect Dis; 2004 Apr 01; 189(7):1304-12. PubMed ID: 15031801 [Abstract] [Full Text] [Related]
11. Nasal vaccination with P6 outer membrane protein and alpha-galactosylceramide induces nontypeable Haemophilus influenzae-specific protective immunity associated with NKT cell activation and dendritic cell expansion in nasopharynx. Noda K, Kodama S, Umemoto S, Abe N, Hirano T, Suzuki M. Vaccine; 2010 Jul 12; 28(31):5068-74. PubMed ID: 20478344 [Abstract] [Full Text] [Related]
12. Study on specific mucosal immunity by intranasal immunization of outer membrane protein P6 of Haemophilus influenzae with cholera toxin B subunit. Hotomi M, Yokoyama M, Kuki K, Togawa A, Yamanaka N. Acta Otolaryngol Suppl; 1996 Jul 12; 523():150-2. PubMed ID: 9082765 [Abstract] [Full Text] [Related]
13. A single nasal dose of fms-like tyrosine kinase receptor-3 ligand, but not peritoneal application, enhances nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx. Kodama S, Hirano T, Noda K, Abe N, Suzuki M. Vaccine; 2010 Mar 16; 28(13):2510-6. PubMed ID: 20117272 [Abstract] [Full Text] [Related]
14. Local application of CpG oligodeoxynucleotide enhances nontypeable Haemophilus influenzae-specific mucosal IgA responses in the middle ear. Kodama S, Hirano T, Abe N, Suzuki M. Acta Otolaryngol; 2007 Aug 16; 127(8):809-15. PubMed ID: 17762989 [Abstract] [Full Text] [Related]
16. Eustachian tube possesses immunological characteristics as a mucosal effector site and responds to P6 outer membrane protein of nontypeable Haemophilus influenzae. Kodama S, Hirano T, Suenaga S, Abe N, Suzuki M. Vaccine; 2006 Feb 13; 24(7):1016-27. PubMed ID: 16242817 [Abstract] [Full Text] [Related]